Literature DB >> 27485818

Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.

Stefano Rossetti1, Andrzej J Wierzbicki1, Nicoletta Sacchi1.   

Abstract

Upregulation of RNA Polymerase (Pol I)-mediated transcription of rRNA and increased ribogenesis are hallmarks of breast cancer. According to several datasets, including The Cancer Genome Atlas (TCGA), amplification/upregulation of genes encoding for basal components of the Pol I transcriptional machinery is frequent at different breast cancer stages. Here we show that knock down of the RNA polymerase I-specific transcription initiation factor RRN3 (TIF-IA) in breast cancer cells is sufficient to reduce rRNA synthesis and inhibit cell proliferation, and second that stable ectopic expression of RRN3 in human mammary epithelial (HME1) cells, by increasing rRNA transcription, confers increased sensitivity to the anti-proliferative effects of a selective Pol I inhibitor. Further, RRN3-overexpressing HME1 cells, when grown in in vitro 3-dimensional (3D) culture, develop into morphologically aberrant acinar structures lacking a lumen and filled with proliferative cells, thus acquiring a morphology resembling in situ ductal breast cancer lesions (DCIS). Consequently, interference with RRN3 control of Pol I transcription seems capable of both compromising mammary epithelial morphogenetic processes at early breast cancer stages, and driving breast cancer progression by fostering proliferation.

Entities:  

Keywords:  ADH; DCIS; RNA polymerase I; RRN3/TIF-IA; Ribosomal gene transcription; breast cancer; mammary epithelial morphogenesis; rRNA; small molecule drugs

Mesh:

Substances:

Year:  2016        PMID: 27485818      PMCID: PMC5026817          DOI: 10.1080/15384101.2016.1215385

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  33 in total

1.  Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.

Authors:  Le Xuan Truong Nguyen; Beverly S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 2.  Epigenetic control of RNA polymerase I transcription in mammalian cells.

Authors:  Ingrid Grummt; Gernot Längst
Journal:  Biochim Biophys Acta       Date:  2012-10-12

3.  Central command.

Authors:  Mitch Leslie
Journal:  Science       Date:  2014-08-01       Impact factor: 47.728

Review 4.  Targeting the nucleolus for cancer intervention.

Authors:  Jaclyn E Quin; Jennifer R Devlin; Donald Cameron; Kate M Hannan; Richard B Pearson; Ross D Hannan
Journal:  Biochim Biophys Acta       Date:  2014-01-02

Review 5.  Regulation of ribosomal gene expression in cancer.

Authors:  Le Xuan Truong Nguyen; Aparna Raval; Jacqueline S Garcia; Beverly S Mitchell
Journal:  J Cell Physiol       Date:  2015-06       Impact factor: 6.384

6.  Patterns of chromosomal alterations in breast ductal carcinoma in situ.

Authors:  E Shelley Hwang; Sandy DeVries; Karen L Chew; Dan H Moore; Karla Kerlikowske; Ann Thor; Britt-Marie Ljung; Frederic M Waldman
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

Review 7.  Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes.

Authors:  Sarah J Goodfellow; Joost C B M Zomerdijk
Journal:  Subcell Biochem       Date:  2013

8.  mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability.

Authors:  Christine Mayer; Jian Zhao; Xuejun Yuan; Ingrid Grummt
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

9.  c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation.

Authors:  Gretchen Poortinga; Meaghan Wall; Elaine Sanij; Kasia Siwicki; Jason Ellul; Daniel Brown; Timothy P Holloway; Ross D Hannan; Grant A McArthur
Journal:  Nucleic Acids Res       Date:  2010-12-21       Impact factor: 16.971

10.  Downregulation of rRNA transcription triggers cell differentiation.

Authors:  Yuki Hayashi; Takao Kuroda; Hiroyuki Kishimoto; Changshan Wang; Atsushi Iwama; Keiji Kimura
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more
  6 in total

1.  Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.

Authors:  Zsofia Turi; Marketa Senkyrikova; Martin Mistrik; Jiri Bartek; Pavel Moudry
Journal:  Cell Cycle       Date:  2017-12-10       Impact factor: 4.534

2.  MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma.

Authors:  Sheetanshu Saproo; Shashanka S Sarkar; Ekta Gupta; Sourav Chattopadhyay; Aarzoo Charaya; Siddhant Kalra; Gaurav Ahuja; Srivatsava Naidu
Journal:  Cancer Gene Ther       Date:  2022-10-17       Impact factor: 5.854

3.  Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer.

Authors:  Stefano Rossetti; Andrzej J Wierzbicki; Nicoletta Sacchi
Journal:  Oncotarget       Date:  2017-12-22

4.  Analysis and identification of m6A RNA methylation regulators in metastatic osteosarcoma.

Authors:  Hanji Huang; Xiaofei Cui; Xiong Qin; Kanglu Li; Guohua Yan; Dejie Lu; Mingjun Zheng; Ziwei Hu; Danqing Lei; Nihan Lan; Li Zheng; Zhenchao Yuan; Bo Zhu; Jinmin Zhao
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-11       Impact factor: 8.886

5.  PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.

Authors:  Hsiang-I Tsai; Yanping Wu; Rui Huang; Dandan Su; Yingyi Wu; Xiaoyan Liu; Linglu Wang; Zhanxue Xu; Yuxin Pang; Chong Sun; Chao He; Fan Shu; Haitao Zhu; Dongqing Wang; Fang Cheng; Laiqiang Huang; Hongbo Chen
Journal:  Acta Pharm Sin B       Date:  2021-10-30       Impact factor: 14.903

Review 6.  Ribosomal RNA Transcription Regulation in Breast Cancer.

Authors:  Cecelia M Harold; Amber F Buhagiar; Yan Cheng; Susan J Baserga
Journal:  Genes (Basel)       Date:  2021-03-29       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.